Bluegrass Beacon: Drug pricing — bustling marketplace or stifling monopoly?

By JIM WATERS Bluegrass Institute for Public Policy Solutions Friday, Nov. 17, 2017 — You probably sense that few drug makers can compete in arenas with the likes of a mega-pharmaceutical giant like AbbVie, which employs 30,000, raked in $26 billion last year alone and deserves blame for some of those irksome TV prescription-drug commercials. You’ll … Continue reading Bluegrass Beacon: Drug pricing — bustling marketplace or stifling monopoly?